Amedeo Smart

Free Medical Literature Service


 

Amedeo

Liver Diseases

  Free Subscription

Articles published in
AJR Am J Roentgenol
    August 2022
  1. KIM TH, Woo S, Ebrahimzadeh S, Mclnnes MDF, et al
    Hepatic Adenoma Subtypes on Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI: Systematic Review and Meta-Analysis.
    AJR Am J Roentgenol. 2022 Aug 3. doi: 10.2214/AJR.22.27989.
    >> Share

  2. TAVRI S
    Editorial Comment: FIPS Score-A New Tool With Improved Potential to Predict Post-TIPS Outcomes.
    AJR Am J Roentgenol. 2022;219:268.
    >> Share

  3. CUNHA GM, Delgado TI, Middleton MS, Liew S, et al
    Automated CNN-Based Analysis Versus Manual Analysis for MR Elastography in Nonalcoholic Fatty Liver Disease: Intermethod Agreement and Fibrosis Stage Discriminative Performance.
    AJR Am J Roentgenol. 2022;219:224-232.
    >> Share

    July 2022
  4. CANNELLA R
    Editorial Comment: LI-RADS Provides High Accuracy for Liver Transplant Eligibility in High-Risk Patients.
    AJR Am J Roentgenol. 2022;219:96.
    >> Share

  5. HUBER AT, Obmann V
    Beyond the AJR: Prognostic Value of a Single Baseline Liver Stiffness Measurement by MR Elastography in Patients With Chronic Liver Disease.
    AJR Am J Roentgenol. 2022;219:169.
    >> Share

    June 2022
  6. DILLMAN JR, Thapaliya S, Tkach JA, Trout AT, et al
    Quantification of Hepatic Steatosis by Ultrasound: Prospective Comparison to MRI Proton-Density Fat Fraction as Reference Standard.
    AJR Am J Roentgenol. 2022 Jun 8. doi: 10.2214/AJR.22.27878.
    >> Share

  7. BASTAWROUS S
    Editorial Comment: Factors Impacting Ultrasound LI-RADS Visualization Scores-Optimizing Future Quality Assurance and Standards.
    AJR Am J Roentgenol. 2022;218:1020.
    >> Share

    May 2022
  8. HULL NC
    Editorial Comment: Hepatocellular Carcinoma Screening Guidelines Are Needed in Children With Predisposing Conditions.
    AJR Am J Roentgenol. 2022 May 18. doi: 10.2214/AJR.22.27975.
    >> Share

  9. DASTMALCHIAN S, Aryafar H, Tavri S
    Intravascular Ultrasound Guidance for Transjugular Intrahepatic Portosystemic Shunt Procedures: A Review.
    AJR Am J Roentgenol. 2022 May 18. doi: 10.2214/AJR.22.27626.
    >> Share

  10. KIM SH, Navot B, Guniganti P, Gavlin A, et al
    Liver Transplant for Non-Hepatocellular Malignancies: A Review for Radiologists.
    AJR Am J Roentgenol. 2022 May 11. doi: 10.2214/AJR.22.27783.
    >> Share

  11. REES MA, Schooler GR, Chavhan GB, Towbin AJ, et al
    Imaging Features of Hepatocellular Carcinoma in Children With and Without Underlying Risk Factors.
    AJR Am J Roentgenol. 2022 May 11. doi: 10.2214/AJR.22.27600.
    >> Share

  12. LUNA A
    Editorial Comment: Integrated Diagnosis of Hepatocellular Carcinoma-An Opportunity for Abdominal Radiologists.
    AJR Am J Roentgenol. 2022 May 4:12. doi: 10.2214/AJR.22.27611.
    >> Share

  13. CANNELLA R, Lewis S, da Fonseca L, Ronot M, et al
    Immunotherapy-Based Treatments of Hepatocellular Carcinoma: AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2022 May 4. doi: 10.2214/AJR.22.27633.
    >> Share

    April 2022
  14. LI L, Zheng W, Wang J, Han J, et al
    Contrast-Enhanced Ultrasound Using Perfluorobutane: Impact of Proposed Modified LI-RADS Criteria on Hepatocellular Carcinoma Detection.
    AJR Am J Roentgenol. 2022 Apr 20. doi: 10.2214/AJR.22.27521.
    >> Share

  15. WANG X, Guo Y, Yang L, Luo X, et al
    Use of an Intrahepatic Arterial Targeting Wire for Guiding Portal Vein Puncture During TIPS Creation in Patients With Obliterative Portal Vein Thrombosis.
    AJR Am J Roentgenol. 2022 Apr 13. doi: 10.2214/AJR.22.27675.
    >> Share

  16. KURTZ D, Wachsberg RH
    Factitious Nodularity of the Anterior Liver Surface on Prone Abdominal CT: A Potential Mimic of Cirrhosis.
    AJR Am J Roentgenol. 2022 Apr 13. doi: 10.2214/AJR.22.27669.
    >> Share

  17. FETZER DT
    Beyond the AJR: Shorter Ultrasound Screening Intervals for Hepatocellular Carcinoma Improve Patient Outcomes.
    AJR Am J Roentgenol. 2022;218:761.
    >> Share

    March 2022
  18. YOUNG S
    Editorial Comment: Echocardiography-Should It Be Routine Before Elective TIPS?
    AJR Am J Roentgenol. 2022 Mar 2. doi: 10.2214/AJR.22.27580.
    >> Share

  19. TANG A
    Editorial Comment: LI-RADS LR-2 and LR-3 Observations-Benign or Not Benign?
    AJR Am J Roentgenol. 2022;218:471.
    >> Share

    February 2022
  20. ALI A, Sarwar A, Patwardhan VR, Fraiche AM, et al
    Echocardiographic and Other Preprocedural Predictors of Heart Failure After TIPS Placement in Patients With Cirrhosis: A Single-Center 15-Year Analysis.
    AJR Am J Roentgenol. 2022 Feb 16. doi: 10.2214/AJR.21.26947.
    >> Share

  21. LOY LM, Low HM, Choi JY, Rhee HJ, et al
    Variant Hepatocellular Carcinoma Subtypes According to the 2019 WHO Classification: An Imaging-Focused Review.
    AJR Am J Roentgenol. 2022 Feb 16. doi: 10.2214/AJR.21.26982.
    >> Share

  22. BAE JS, Lee DH, Lee SM, Suh KS, et al
    Performance of LI-RADS Version 2018 on CT for Determining Eligibility for Liver Transplantation According to Milan Criteria in Patients at High Risk for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2022 Feb 9. doi: 10.2214/AJR.21.27186.
    >> Share

  23. YANG C, Chen Q, Zhou C, Liu J, et al
    FIPS Score for Prediction of Survival After TIPS Placement: External Validation and Comparison With Traditional Risk Scores in a Cohort of Chinese Patients With Cirrhosis.
    AJR Am J Roentgenol. 2022 Feb 9. doi: 10.2214/AJR.21.27301.
    >> Share

  24. MELLNICK VM
    Editorial Comment: Increased liver lesion visualization on CT without increased cost.
    AJR Am J Roentgenol. 2022 Feb 2. doi: 10.2214/AJR.22.27391.
    >> Share

  25. GEE MS
    Editorial Comment: Novel Associations Between Quantitative MRI Metrics and Clinical Risk Scores in Young Patients With Autoimmune Liver Disease.
    AJR Am J Roentgenol. 2022 Feb 2. doi: 10.2214/AJR.22.27453.
    >> Share

    January 2022
  26. MCCRARY J, Trout AT, Mahalingam N, Singh R, et al
    Associations Between Quantitative MRI Metrics and Clinical Risk Scores in Children and Young Adults With Autoimmune Liver Disease.
    AJR Am J Roentgenol. 2022 Jan 26. doi: 10.2214/AJR.21.27204.
    >> Share

  27. CHO KJ
    Editorial Comment: Bland Hepatic Artery Embolization (HAE) for Hepatic Malignancy-Can Bland HAE be Performed on an Outpatient Basis?
    AJR Am J Roentgenol. 2022 Jan 19. doi: 10.2214/AJR.22.27384.
    >> Share

  28. BONGERS MN, Walter S, Fritz J, Bier G, et al
    Interindividual Comparison of Frequency-Selective Nonlinear Blending to Conventional CT for Detection of Focal Liver Lesions Using MRI as the Reference Standard.
    AJR Am J Roentgenol. 2022 Jan 12. doi: 10.2214/AJR.21.26922.
    >> Share

  29. RMILAH AA, Qrareya MN, Fleming C, Alkurashi AK, et al
    Association of Cirrhosis and Other Patient and Procedural Characteristics With Postembolization Syndrome after Bland Hepatic Artery Embolization for Hepatic Malignancy.
    AJR Am J Roentgenol. 2022 Jan 5. doi: 10.2214/AJR.21.26806.
    >> Share

  30. DILLMAN JR, Franck MD, Gandhi D, Pednekar AS, et al
    Agreement Between Automated and Clinically Reported Manual ROI-Based MR Elastography Liver Stiffness Measurements in Children and Young Adults.
    AJR Am J Roentgenol. 2022;218:163-164.
    >> Share

    December 2021
  31. XIAN MF, Huang Y, Xie WX, Pan KM, et al
    LR-M Observations on Contrast-Enhanced Ultrasound: Detection of Hepatocellular Carcinoma Using Additional Features in Comparison with Current LI-RADS Criteria.
    AJR Am J Roentgenol. 2021 Dec 15. doi: 10.2214/AJR.21.26837.
    >> Share

  32. LIU PS
    Editorial Comment: Is Quantitative CT Fat Fraction Ready For Prime Time?
    AJR Am J Roentgenol. 2021 Dec 15. doi: 10.2214/AJR.21.27184.
    >> Share

  33. FETZER DT, Browning T, Xi Y, Yokoo T, et al
    Associations of Ultrasound LI-RADS Visualization Score With Examination-, Sonographer-, and Radiologist-Factors: Retrospective Assessment in Over 10,000 Examinations.
    AJR Am J Roentgenol. 2021 Dec 15. doi: 10.2214/AJR.21.26735.
    >> Share

  34. SCHIMA W
    Editorial Comment: Which MRI Contrast Agent for Hepatocellular Carcinoma Diagnosis in LI-RADS? The Fog is Lifting.
    AJR Am J Roentgenol. 2021 Dec 8. doi: 10.2214/AJR.21.27171.
    >> Share

    November 2021
  35. GUO Z, Blake GM, Graffy PM, Sandfort V, et al
    Hepatic Steatosis: CT-based Prevalence in Adults in China and the United States and Associations with Age, Sex, and Body Mass Index.
    AJR Am J Roentgenol. 2021 Nov 24. doi: 10.2214/AJR.21.26728.
    >> Share

  36. RONG D, He B, Tang W, Xie S, et al
    Comparison of Gadobenate-Enhanced MRI and Gadoxetate-Enhanced MRI for Hepatocellular Carcinoma Detection Using LI-RADS Version 2018: A Prospective Intraindividual Randomized Study.
    AJR Am J Roentgenol. 2021 Nov 24. doi: 10.2214/AJR.21.26818.
    >> Share

    October 2021
  37. HAO F, Eghbalieh N, So A, Lee EW, et al
    Hepatic Plexus Nerve Block for Microwave Ablation of Hepatic Tumors.
    AJR Am J Roentgenol. 2021 Oct 27. doi: 10.2214/AJR.21.26779.
    >> Share

  38. STRUYCKEN L, Patel M, Kuo P, Hennemeyer C, et al
    Clinical and Dosimetric Implications of Calculating Lung Shunt Fraction for Hepatic Yttrium-90 Radioembolization Using SPECT/CT Versus Planar Scintigraphy.
    AJR Am J Roentgenol. 2021 Oct 27. doi: 10.2214/AJR.21.26663.
    >> Share

  39. CHERNYAK V
    Editorial Comment: Transitional or Hepatobiliary Phase Hypointensity Improves Sensitivity Without Loss of Specificity for Pathologically Viable HCC After Locoregional Treatment.
    AJR Am J Roentgenol. 2021 Oct 20. doi: 10.2214/AJR.21.26949.
    >> Share

  40. CHERNYAK V, van der Pol CB, Vernuccio F, Yoshimitsu K, et al
    The Global Reading Room: Imaging Detection of Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2021 Oct 13. doi: 10.2214/AJR.21.26909.
    >> Share

  41. RANATHUNGA D, Osman H, Islam N, McInnes MD, et al
    Progression Rates of LR-2 and LR-3 Observations on MRI to Higher LI-RADS Categories in Patients at High Risk for Hepatocellular Carcinoma: A Retrospective Study.
    AJR Am J Roentgenol. 2021 Oct 13. doi: 10.2214/AJR.21.26376.
    >> Share

  42. LIU J, Ma J, Yang C, Ye T, et al
    Reply to "Factors in Spleen Size After TIPS Placement".
    AJR Am J Roentgenol. 2021;217:1013.
    >> Share

  43. GEMERY JM, Munger DP, Hoffer EK
    Factors in Spleen Size After TIPS Placement.
    AJR Am J Roentgenol. 2021;217:1013.
    >> Share

  44. FERRAIOLI G
    Beyond the AJR: "Two-Dimensional Shear Wave Elastography Predicts Survival in Advanced Chronic Liver Disease".
    AJR Am J Roentgenol. 2021;217:1012.
    >> Share

    September 2021
  45. DOHARE N, Madhusudhan KS, Malik R, Das P, et al
    Utility of Hepatic 2D Shear-Wave Elastography in Monitoring Response to Image-Guided Intervention in Children With Chronic Budd-Chiari Syndrome: A Prospective Study.
    AJR Am J Roentgenol. 2021 Sep 29. doi: 10.2214/AJR.21.26547.
    >> Share

  46. KIM YY, Kim MJ, Yoon JK, Shin J, et al
    Incorporation of Ancillary MRI Features into the LI-RADS Treatment Response Algorithm: Impact on Diagnostic Performance After Locoregional Treatment for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2021 Sep 29. doi: 10.2214/AJR.21.26677.
    >> Share

  47. REIZINE E, Chalaye J, Mule S, Regnault H, et al
    Utility of Early Posttreatment PET/CT Evaluation Using FDG or (18)F-FCH to Predict Response to (90)Y Radioembolization in Patients With Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2021 Sep 8. doi: 10.2214/AJR.21.26485.
    >> Share

    August 2021
  48. SHARBIDRE KG
    Editorial Comment: Recurrence of Hepatocellular Carcinoma in Liver Transplants-Microvascular Invasion and Pathologic Staging of the Explant Liver.
    AJR Am J Roentgenol. 2021 Aug 18. doi: 10.2214/AJR.21.26681.
    >> Share

  49. CUNHA GM, Hosseini M, Furlan A, Fowler K, et al
    Hepatocellular Carcinoma Staging: Differences Between Radiologic and Pathologic Systems and Relevance to Patient Selection and Outcomes in Liver Transplantation.
    AJR Am J Roentgenol. 2021 Aug 18. doi: 10.2214/AJR.21.26436.
    >> Share

    July 2021
  50. SEVCO TJ, Masch WR, Maturen KE, Mendiratta-Lala M, et al
    Ultrasound (US) LI-RADS: Outcomes of Category US-3 Observations.
    AJR Am J Roentgenol. 2021 Jul 14:1-7. doi: 10.2214/AJR.20.23447.
    >> Share

  51. PAUL RK, Vazirani R, McDermott JC, Kliewer MA, et al
    Identification of the Most Important Subset of Doppler, Laboratory, and Clinical Parameters for Serial TIPS Evaluation.
    AJR Am J Roentgenol. 2021;217:164-171.
    >> Share

    June 2021
  52. CHU HH, Kim JH, Shin YM, Won HJ, et al
    Percutaneous Radiofrequency Ablation for Recurrent Intrahepatic Cholangiocarcinoma After Curative Resection: Multivariable Analysis of Factors Predicting Survival Outcomes.
    AJR Am J Roentgenol. 2021 Jun 2:1-7. doi: 10.2214/AJR.20.23461.
    >> Share

  53. ARAKI T, Imaizumi A, Okada H, Sasaki Y, et al
    Anatomy of Left Inferior Phrenic Vein in Patients Without Portal Hypertension.
    AJR Am J Roentgenol. 2021 Jun 2:1-7. doi: 10.2214/AJR.20.23106.
    >> Share

    May 2021
  54. RIDDELL AM, Torkzad MR, Koh DM
    Reply to "Additional Considerations on Use of Abbreviated Liver MRI in Patients With Colorectal Liver Metastases".
    AJR Am J Roentgenol. 2021 May 19:W1-W2. doi: 10.2214/AJR.21.25747.
    >> Share

  55. GRANATA V, Fusco R, Petrillo A
    Additional Considerations on Use of Abbreviated Liver MRI in Patients With Colorectal Liver Metastases.
    AJR Am J Roentgenol. 2021 May 19:W1. doi: 10.2214/AJR.21.25652.
    >> Share

  56. MALONE CD
    Editorial Comment on "Ultrasound-Guided Portal Vein Access and Percutaneous Wire Placement in the Portal Vein Are Associated With Shorter Procedure Times and Lower Radiation Doses During TIPS Placement".
    AJR Am J Roentgenol. 2021;216:1299.
    >> Share

    April 2021
  57. ROBBINS AJ, Ritter S, Markese M, Skube ME, et al
    Atypical Hepatic Steatosis Patterns on MRI After Total Pancreatectomy With Islet Autotransplant.
    AJR Am J Roentgenol. 2021 Apr 28:1-7. doi: 10.2214/AJR.20.23303.
    >> Share

  58. CHAVHAN GB, Yoo SJ, Lam CZ, Khanna G, et al
    Abdominal Imaging of Children and Young Adults With Fontan Circulation: Pathophysiology and Surveillance.
    AJR Am J Roentgenol. 2021 Apr 28:1-11. doi: 10.2214/AJR.20.23404.
    >> Share

  59. SQUIRES JH, McCarville MB
    Contrast-Enhanced Ultrasound in Children: Implementation and Key Diagnostic Applications.
    AJR Am J Roentgenol. 2021 Apr 28. doi: 10.2214/AJR.21.25713.
    >> Share

  60. KIM B, Won JH, Kim J, Kwon Y, et al
    Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma: Radiologic and Clinical Factors Predictive of Survival.
    AJR Am J Roentgenol. 2021 Apr 14:1-8. doi: 10.2214/AJR.20.23213.
    >> Share

  61. CHEN Y, Xia Y, Tolat PP, Long L, et al
    Comparison of Conventional Gadoxetate Disodium-Enhanced MRI Features and Radiomics Signatures With Machine Learning for Diagnosing Microvascular Invasion.
    AJR Am J Roentgenol. 2021 Apr 7:1-11. doi: 10.2214/AJR.20.23255.
    >> Share

  62. FERRAIOLI G, Barr RG
    Quantification of Liver Steatosis: Is CT Equivalent to PDFF?
    AJR Am J Roentgenol. 2021;216:W14.
    >> Share

  63. CORNMAN-HOMONOFF J, Madoff DC
    Commentary on: "Rebleeding and Mortality Risk Are Increased by ACLF but Reduced by Pre-emptive TIPS".
    AJR Am J Roentgenol. 2021;216:878.
    >> Share

    March 2021
  64. YOUNG S, Cam I, Gencturk M
    Reply to "Utility of Ultrasound Guidance During Direct Intrahepatic Portal Shunt Placement in Pediatric Patients With Budd-Chiari Syndrome".
    AJR Am J Roentgenol. 2021 Mar 24:W1. doi: 10.2214/AJR.20.24769.
    >> Share

  65. LUDWIG DR, Fraum TJ, Ballard DH, Narra VR, et al
    Imaging Biomarkers of Hepatic Fibrosis: Reliability and Accuracy of Hepatic Periportal Space Widening and Other Morphologic Features on MRI.
    AJR Am J Roentgenol. 2021 Mar 17:1-11. doi: 10.2214/AJR.20.23099.
    >> Share

  66. MADHUSUDHAN KS, Sharma S
    Utility of Ultrasound Guidance During Direct Intrahepatic Portal Shunt Placement in Pediatric Patients With Budd-Chiari Syndrome.
    AJR Am J Roentgenol. 2021 Mar 17:W1. doi: 10.2214/AJR.20.24556.
    >> Share

  67. SARWAR A, Esparaz AM, Chakrala N, Mangano M, et al
    Efficacy of TIPS Reduction for Refractory Hepatic Encephalopathy, Right Heart Failure, and Liver Dysfunction.
    AJR Am J Roentgenol. 2021 Mar 11:1-6. doi: 10.2214/AJR.19.22497.
    >> Share

  68. LOKKEN RP, Kerlan RK , Jr, Chung YC, Chen YF, et al
    Hepatic Toxicity After Selective Chemoembolization Is Associated With Decreased Survival Among Patients With Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2021 Mar 11:1-8. doi: 10.2214/AJR.20.23478.
    >> Share

  69. WANG Y, Liang W
    Quality Control of Radiomics Study to Differentiate Benign and Malignant Hepatic Lesions.
    AJR Am J Roentgenol. 2021;216:W12.
    >> Share

  70. HOMAYOUNIEH F, Kalra MK
    Reply to "Quality Control of Radiomics Study to Differentiate Benign and Malignant Hepatic Lesions".
    AJR Am J Roentgenol. 2021;216:W13.
    >> Share

  71. LEE GM, Stowell JT, Pope K, Carter BW, et al
    Lymphatic Pathways of the Thorax: Predictable Patterns of Spread.
    AJR Am J Roentgenol. 2021;216:649-658.
    >> Share

    February 2021
  72. WU V, Li MD, Goodwin JS, Wehrenberg-Klee EP, et al
    Yttrium-90 Hepatic Radioembolization for Advanced Chemorefractory Metastatic Colorectal Cancer: Survival Outcomes Based on Right-Versus Left-Sided Primary Tumor Location.
    AJR Am J Roentgenol. 2021 Feb 17. doi: 10.2214/AJR.20.25315.
    >> Share

  73. RIEDESEL EL
    Editorial Comment: Liver Fat Quantification by Ultrasound-Potential to Change Diagnosis and Management of Pediatric NAFLD.
    AJR Am J Roentgenol. 2021 Feb 10. doi: 10.2214/AJR.21.25594.
    >> Share

  74. VAN DER POL CB, Dhindsa K, Shergill R, Zha N, et al
    MRI Liver Imaging Reporting and Data System (LI-RADS) Version 2018: Impact of and Reduction in Ancillary Features.
    AJR Am J Roentgenol. 2021 Feb 3:1-8. doi: 10.2214/AJR.20.23031.
    >> Share

  75. MARKS RM, Masch WR, Chernyak V
    LI-RADS: Past, Present, and Future, From the AJR Special Series on Radiology Reporting and Data Systems.
    AJR Am J Roentgenol. 2021;216:295-304.
    >> Share

    January 2021
  76. TORKZAD MR, Riddell AM, Chau I, Cunningham D, et al
    Clinical Performance of Abbreviated Liver MRI for the Follow-Up of Patients With Colorectal Liver Metastases.
    AJR Am J Roentgenol. 2021 Jan 27:1-8. doi: 10.2214/AJR.20.22854.
    >> Share

  77. LUBNER MG, Graffy PM, Said A, Watson R, et al
    Utility of Multiparametric CT for Identification of High-Risk NAFLD.
    AJR Am J Roentgenol. 2021 Jan 21:1-10. doi: 10.2214/AJR.20.22842.
    >> Share

  78. BUROS C, Furlan A
    Beyond the AJR: "Magnetic Resonance Elastography versus Transient Elastography in the Prediction of Complications after Resection for Hepatocellular Carcinoma".
    AJR Am J Roentgenol. 2021 Jan 20. doi: 10.2214/AJR.21.25458.
    >> Share

  79. BAIKPOUR M, Ozturk A, Dhyani M, Mercaldo ND, et al
    Reply to "Biomarkers for High-Risk Nonalcoholic Fatty Liver Disease: Beyond Portal Venous Pulsatility Index".
    AJR Am J Roentgenol. 2021;216:W2.
    >> Share

  80. LIZARAZO DA, Romero J, Gonzalez-Gomez S
    Biomarkers for High-Risk Nonalcoholic Fatty Liver Disease: Beyond Portal Venous Pulsatility Index.
    AJR Am J Roentgenol. 2021;216:W1.
    >> Share

    December 2020
  81. BOYUM JH, Sheedy SP, Graham RP, Olson JT, et al
    Hepatic Mucinous Cystic Neoplasm Versus Simple Biliary Cyst: Assessment of Distinguishing Imaging Features Using CT and MRI.
    AJR Am J Roentgenol. 2020 Dec 23:1-9. doi: 10.2214/AJR.20.22768.
    >> Share

  82. KINNEY TB
    Editorial Comment: A Cautionary Experience with Drug-Eluting Beads Transarterial Chemoembolization for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2020 Dec 23. doi: 10.2214/AJR.20.25284.
    >> Share

  83. YANG Q, Cai Q, Wen H, Mao Y, et al
    The CT and MRI Features of Primary Intrahepatic Lymphoepithelioma-Like Cholangiocarcinoma.
    AJR Am J Roentgenol. 2020 Dec 16:1-10. doi: 10.2214/AJR.20.22937.
    >> Share

  84. RENTON M, Kielar A
    Beyond the AJR: "Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications".
    AJR Am J Roentgenol. 2020 Dec 9. doi: 10.2214/AJR.20.25188.
    >> Share

  85. CHENG J, Qiu M, Zhang Y, Hong N, et al
    Enhanced Rim on MDCT of Colorectal Liver Metastases: Assessment of Ability to Predict Progression-Free Survival and Response to Bevacizumab-Based Chemotherapy.
    AJR Am J Roentgenol. 2020;215:1377-1383.
    >> Share

    November 2020
  86. ZHANG L, Sun JH, Ji JS, Zhong BY, et al
    Imaging Changes and Clinical Complications After Drug-Eluting Beads Versus Conventional Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Multicenter Study.
    AJR Am J Roentgenol. 2020 Nov 27. doi: 10.2214/AJR.20.24708.
    >> Share

    October 2020
  87. KIM YY, Choi JY, Kim SU, Lee M, et al
    MRI Ancillary Features for LI-RADS Category 3 and 4 Observations: Improved Categorization to Indicate the Risk of Hepatic Malignancy.
    AJR Am J Roentgenol. 2020 Oct 14:1-9. doi: 10.2214/AJR.20.22802.
    >> Share

  88. STRNAD BS, Ludwig DR, Gilcrease-Garcia B, Fraum TJ, et al
    Contemporary Imaging of the Surgically Placed Hepatic Arterial Infusion Chemotherapy Pump.
    AJR Am J Roentgenol. 2020 Oct 7. doi: 10.2214/AJR.20.24437.
    >> Share

  89. KEE-SAMPSON J
    Editorial Comment on "Thermal Ablation Versus Stereotactic Body Radiotherapy Following Transarterial Chemoembolization for Inoperable Hepatocellular Carcinoma: A Propensity Score Weighted Analysis".
    AJR Am J Roentgenol. 2020 Oct 7. doi: 10.2214/AJR.20.24849.
    >> Share

    September 2020
  90. NABAVIZADEH N, Jahangiri Y, Rahmani R, Tomozawa Y, et al
    Thermal Ablation Versus Stereotactic Body Radiotherapy Following Transarterial Chemoembolization for Inoperable Hepatocellular Carcinoma: A Propensity Score Weighted Analysis.
    AJR Am J Roentgenol. 2020 Sep 30. doi: 10.2214/AJR.20.24117.
    >> Share

  91. BORHANI AA
    Editorial Comment on "Liver Steatosis Categorization on Contrast-Enhanced CT Using a Fully-Automated Deep Learning Volumetric Segmentation Tool: Evaluation in 1,204 Heathy Adults Using Unenhanced CT as Reference Standard".
    AJR Am J Roentgenol. 2020 Sep 30. doi: 10.2214/AJR.20.24764.
    >> Share

  92. PICKHARDT PJ, Blake GM, Graffy PM, Sandfort V, et al
    Liver Steatosis Categorization on Contrast-Enhanced CT Using a Fully-Automated Deep Learning Volumetric Segmentation Tool: Evaluation in 1,204 Heathy Adults Using Unenhanced CT as Reference Standard.
    AJR Am J Roentgenol. 2020 Sep 16. doi: 10.2214/AJR.20.24415.
    >> Share

  93. MICHELL H, Johnston GP, Chopra P, Scriver GM, et al
    Cholecystostomy as an Exclusive Access to Remove Cystic, Common Hepatic, and Common Bile Duct Stones.
    AJR Am J Roentgenol. 2020 Sep 9:1-5. doi: 10.2214/AJR.19.22469.
    >> Share

  94. PHAM JT, Kalantari J, Ji C, Chang JH, et al
    Quantitative CT Predictors of Portal Venous Intervention in Uncontrolled Variceal Bleeding.
    AJR Am J Roentgenol. 2020 Sep 9:1-5. doi: 10.2214/AJR.19.22460.
    >> Share

  95. KIERANS AS, Song C, Gavlin A, Roudenko A, et al
    Diagnostic Performance of LI-RADS Version 2018, LI-RADS Version 2017, and OPTN Criteria for Hepatocellular Carcinoma.
    AJR Am J Roentgenol. 2020 Sep 2:1-8. doi: 10.2214/AJR.20.22772.
    >> Share

  96. ANDREWS JC
    Editorial Comment on "Retrospective Comparison of Clinical Outcomes Following Splenic Vein Stenting and Splenic Arterial Embolization in Sinistral Portal Hypertension-Related Gastrointestinal Bleeding".
    AJR Am J Roentgenol. 2020 Sep 2. doi: 10.2214/AJR.20.24486.
    >> Share

  97. MONTI L, Salsano M, Candusso M, Avolio AW, et al
    Diagnosis of Acute Rejection of Liver Grafts in Young Children Using Acoustic Radiation Force Impulse Imaging.
    AJR Am J Roentgenol. 2020 Sep 2:1-9. doi: 10.2214/AJR.19.22057.
    >> Share

    August 2020
  98. WEI B, Zhang L, Tong H, Wang Z, et al
    Retrospective Comparison of Clinical Outcomes Following Splenic Vein Stenting and Splenic Arterial Embolization in Sinistral Portal Hypertension-Related Gastrointestinal Bleeding.
    AJR Am J Roentgenol. 2020 Aug 26. doi: 10.2214/AJR.20.23859.
    >> Share

  99. OLSON MC, Venkatesh SK
    HCC Screening: Is Ultrasound Still Needed at Transplant Centers?-Counterpoint: No, CT/MR is the Way to Go.
    AJR Am J Roentgenol. 2020 Aug 19. doi: 10.2214/AJR.20.24252.
    >> Share

  100. KAMAYA A, Rodgers SK
    HCC Screening: Is Ultrasound Still Needed at Transplant Centers?-Point: Yes, Ultrasound Remains First Line.
    AJR Am J Roentgenol. 2020 Aug 19. doi: 10.2214/AJR.20.24382.
    >> Share

  101. BORRERO R, Valencia S, Triana G
    Are Cutoff Points of Liver Fibrosis in Shear Wave Elastography Really Reliable to Determine Whether Patients Should Undergo Biopsy?
    AJR Am J Roentgenol. 2020;215:W29.
    >> Share

    July 2020
  102. MANCHEC B, Pham E, Noor M, Pepe J, et al
    Contrast-Enhanced CT May Identify High-Risk Esophageal Varices in Patients With Cirrhosis.
    AJR Am J Roentgenol. 2020 Jul 1:1-7. doi: 10.2214/AJR.19.22474.
    >> Share

  103. KIM SW, Kim YR, Choi KH, Cho EY, et al
    Staging of Liver Fibrosis by Means of Semiautomatic Measurement of Liver Surface Nodularity in MRI.
    AJR Am J Roentgenol. 2020 Jul 1:1-7. doi: 10.2214/AJR.19.22041.
    >> Share

    June 2020
  104. CHU HH, Gwon DI, Kim JH, Ko GY, et al
    Drug-Eluting Microsphere Versus Cisplatin-Based Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: Propensity Score-Matched Analysis.
    AJR Am J Roentgenol. 2020 Jun 22:1-8. doi: 10.2214/AJR.19.21669.
    >> Share

    May 2020
  105. YOUNG S, Rostambeigi N, Golzarian J, Lim N, et al
    MELD or Sodium MELD: A Comparison of the Ability of Two Scoring Systems to Predict Outcomes After Transjugular Intrahepatic Portosystemic Shunt Placement.
    AJR Am J Roentgenol. 2020 May 20:1-8. doi: 10.2214/AJR.19.21726.
    >> Share

  106. SMEREKA P, Doshi AM, Lavelle LP, Shanbhogue K, et al
    New Arterial Phase Enhancing Nodules on MRI of Cirrhotic Liver: Risk of Progression to Hepatocellular Carcinoma and Implications for LI-RADS Classification.
    AJR Am J Roentgenol. 2020 May 20:1-8. doi: 10.2214/AJR.19.22033.
    >> Share

  107. HOMAYOUNIEH F, Singh R, Nitiwarangkul C, Lades F, et al
    Semiautomatic Segmentation and Radiomics for Dual-Energy CT: A Pilot Study to Differentiate Benign and Malignant Hepatic Lesions.
    AJR Am J Roentgenol. 2020 May 14:1-8. doi: 10.2214/AJR.19.22164.
    >> Share

  108. SARWAR A, Weinstein JL, Novack V, Chakrala N, et al
    Causes and Rates of 30-Day Readmissions After Transjugular Intrahepatic Portosystemic Shunts.
    AJR Am J Roentgenol. 2020 May 6:1-7. doi: 10.2214/AJR.19.21732.
    >> Share

  109. DRESCHER R, Kuhnel C, Seifert P, Guhne F, et al
    Renal and Intestinal Excretion of (90)Y and (166)Ho After Transarterial Radioembolization of Liver Tumors.
    AJR Am J Roentgenol. 2020;214:1158-1164.
    >> Share

    April 2020
  110. YOUNG S, Golzarain J
    Locoregional Therapies in the Treatment of 3- to 5-cm Hepatocellular Carcinoma: Critical Review of the Literature.
    AJR Am J Roentgenol. 2020 Apr 7:1-12. doi: 10.2214/AJR.19.22098.
    >> Share

  111. BAIKPOUR M, Ozturk A, Dhyani M, Mercaldo ND, et al
    Portal Venous Pulsatility Index: A Novel Biomarker for Diagnosis of High-Risk Nonalcoholic Fatty Liver Disease.
    AJR Am J Roentgenol. 2020;214:786-791.
    >> Share

    March 2020
  112. WANG DC, Jang HJ, Kim TK
    Characterization of Indeterminate Liver Lesions on CT and MRI With Contrast-Enhanced Ultrasound: What Is the Evidence?
    AJR Am J Roentgenol. 2020 Mar 17:1-10. doi: 10.2214/AJR.19.21498.
    >> Share

  113. ROMBERG EK, Tang ER, Chandra T, Podberesky DJ, et al
    Applications of Pediatric Body CT Angiography: What Radiologists Need to Know.
    AJR Am J Roentgenol. 2020 Mar 4:1-12. doi: 10.2214/AJR.19.22274.
    >> Share

    January 2020
  114. EL-ALI AM, McCormick A, Thakrar D, Yilmaz S, et al
    Contrast-Enhanced Ultrasound of Congenital and Infantile Hemangiomas: Preliminary Results From a Case Series.
    AJR Am J Roentgenol. 2020 Jan 22:1-7. doi: 10.2214/AJR.19.22174.
    >> Share

  115. FURLAN A, Tublin ME, Yu L, Chopra KB, et al
    Comparison of 2D Shear Wave Elastography, Transient Elastography, and MR Elastography for the Diagnosis of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    AJR Am J Roentgenol. 2020;214:W20-W26.
    >> Share

    October 2019
  116. KOHNO S, Isoda H, Ono A, Furuta A, et al
    Portal Vein Embolization: Radiological Findings Predicting Future Liver Remnant Hypertrophy.
    AJR Am J Roentgenol. 2019 Oct 23:1-7. doi: 10.2214/AJR.19.21440.
    >> Share

  117. CONSUL N, Menias CO, Lubner MG, Katabathina VS, et al
    A Review of Viral-Related Malignancies and the Associated Imaging Findings.
    AJR Am J Roentgenol. 2019 Oct 8:1-10. doi: 10.2214/AJR.19.21357.
    >> Share

  118. CHUNG JW, Yu JS, Choi JM, Cho ES, et al
    Subtraction Images From Portal Venous Phase Gadoxetic Acid-Enhanced MRI for Observing Washout and Enhancing Capsule Features in LI-RADS Version 2018.
    AJR Am J Roentgenol. 2019 Oct 1:1-9. doi: 10.2214/AJR.18.20797.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016